In order to gain a better insight into the involvement of MBDs in breast cancer, we investigated the expression levels of MeCP2 and MBD2 in human non-neoplastic and neoplastic breast tissue in general using quantitative real-time PCR. This evidence concerns the gene MECP2 and breast carcinoma.